Klemperer M R, Donaldson V H, Rosen F S
J Clin Invest. 1968 Mar;47(3):604-11. doi: 10.1172/JCI105756.
When purified human C'1 esterase is injected intradermally in man, increased vascular permeability results. This effect is not blocked by soybean trypsin inhibitor and is not abolished by pretreatment with the antihistamine, pyribenzamine, or by compound 48/80. Thus, the effect is not due to the release of endogenous histamine. The decreased permeability response of individuals with a specific hereditary deficiency of C'2 is evidence for the complement-dependent nature of this reaction. The apparently normal response to intradermal C'1 esterase developed by individuals with an acquired specific deficiency of C'3 suggests that the vasoactive substance may be derived from one of the early reacting complement components. Characteristic attacks of angioedema have been provoked by the intradermal injection of human C'1 esterase in two individuals with hereditary angioneurotic edema. Patients with hereditary angioneurotic edema are unresponsive to intradermal injections of C'1 esterase immediately after attacks.
当将纯化的人C1酯酶皮内注射到人体时,会导致血管通透性增加。这种效应不受大豆胰蛋白酶抑制剂的阻断,也不会因预先使用抗组胺药、吡苄明或化合物48/80而消除。因此,这种效应不是由于内源性组胺的释放。具有C2特异性遗传性缺陷的个体的通透性反应降低,证明了该反应的补体依赖性性质。具有获得性C3特异性缺陷的个体对皮内注射C1酯酶表现出明显正常的反应,这表明血管活性物质可能源自早期反应的补体成分之一。在两名患有遗传性血管性水肿的个体中,皮内注射人C1酯酶引发了典型的血管性水肿发作。遗传性血管性水肿患者在发作后立即对皮内注射C1酯酶无反应。